The project seeks to expand the existing plant with an additional 5,633 m² modularly designed, including a first phase of 4,700 m² for the production of non-sterile forms and a second phase of 2,500 m² for biotechnological processes, reaching a total capacity of 101 million units per year.
AXIOM led the design, supervision and execution of all stages, developing conceptual, basic and detailed projects in 3D with Revit (LOD-300), in addition to implementing critical systems such as HVAC, purified water, pure steam and fire networks, ensuring compliance with international regulations such as OMS-37, IFC and INVIMA.
